Total | APOE-ε4 status | p | ||
---|---|---|---|---|
Carriers | Non-carriers | |||
(n = 352) | (n = 193, 54.8%) | (n = 159, 47.2%) | ||
Visual read | ||||
Frontal | 48 (13.64) | 33 (68.75) | 15 (31.25) | 0.04* |
PCPCC | 45 (12.78) | 32 (71.11) | 13 (28.89) | 0.02* |
Temporal | 29 (8.24) | 19 (65.51) | 10 (34.49) | 0.22 |
Parietal | 17 (4.83) | 11 (64.70) | 6 (35.30) | 0.46 |
Striatum | 14 (3.98) | 8 (57.14) | 6 (42.86) | 0.86 |
Regional Centiloid | ||||
Frontal | 50 (14.20) | 40 (80.0) | 10 (20.0) | < 0.001* |
PCPCC | 49 (13.92) | 35 (71.42) | 14 (28.57) | 0.01* |
Temporal | 25 (7.10) | 17 (68.0) | 8 (32.0) | 0.17 |
Parietal | 25 (7.10) | 17 (68.0) | 8 (32.0) | 0.17 |
Striatum | 18 (5.11) | 12 (66.67) | 6 (33.33) | 0.30 |